24822-525 : Celontin 300 mg Oral Capsule
NDC: | 24822-525 |
Labeler: | Farmea |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Capsule |
Application #: | NDA010596 |
Rev. Date: |
Appearance:
Markings: | 300;mg;PD525 |
Shapes: |
Capsule |
Colors: |
![]() |
Size (mm): | 19 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |

The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 24822-525-24: 100 CAPSULE IN 1 BOTTLE (24822‑525‑24)
Active Ingredients:
- Methsuximide
Dosage Strength:
- 300 mg
Inactive Ingredients:
- Silicon Dioxide
- D&c Yellow No. 10
- Fd&c Yellow No. 6
- Gelatin, Unspecified
- Sodium Lauryl Sulfate
- Starch, Corn /
Pharmaceutical Classes:
- Anti-epileptic Agent [EPC]
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
Related Products:
Based on records with the same trade name.- 0071-0525 Celontin 300 mg Oral Capsule by Parke-davis Div of Pfizer Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 24794-400Next: 24839-343 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.